Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis
- PMID: 9580479
- DOI: 10.1359/jbmr.1998.13.4.731
Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis
Abstract
The influence of a nonskeletal disease with increased connective tissue synthesis or degradation in the collagen-related markers of bone turnover has been evaluated in 34 women with primary biliary cirrhosis (PBC; age range 41-81 years), a disease with increased hepatic fibrosis, often associated with osteoporosis. Serum osteocalcin (BGP), and carboxy-terminal (PICP) and amino-terminal (PINP) propeptides of type I collagen were assessed as indexes of bone formation, whereas serum tartrate-resistant acid phosphatase (TRAP), and cross-linked carboxy-terminal telopeptide of type I collagen (ICTP), and urinary hydroxyproline (HYP), pyridinoline (PYR), deoxypyridinoline (DPYR), and type I collagen cross-linked N- (NTX) and C-telopeptide (CTX) were measured as markers of bone resorption. The histologic stage of the disease and serum amino-terminal propeptide of type III collagen (PIIINP) as an index of liver fibrogenesis were also evaluated. BGP levels were significantly lower, whereas PICP and PINP levels were higher in patients than in controls. Among the bone resorption markers, serum ICTP and urinary PYR, DPYR, HYP, NTX, and CTX levels were significantly higher in patients than in controls. Serum PIIINP levels were also increased in PBC patients. BGP did not correlate with PICP and PINP, but these markers of bone formation as well as ICTP, PYR, DPYR, and NTX correlated with serum PIIINP levels. Serum TRAP did not correlate with collagen-related markers of bone resorption. Moreover, patients with PIIINP and bilirubin above normal levels had higher PICP, PINP, ICTP PYR, DPYR, CTX, and NTX. These markers correlated with the histologic stage of the disease, but not with osteopenia measured by densitometric procedures in 22 patients. In conclusion, collagen-related markers of bone turnover do not reflect bone remodeling in PBC. The close association of these markers with PIIINP and the clinical and histologic stage of the liver disease suggests that they are influenced by liver collagen metabolism.
Similar articles
-
Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.World J Surg. 1996 Sep;20(7):753-6; discussion 756-7. doi: 10.1007/s002689900114. World J Surg. 1996. PMID: 8678946
-
Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.Bone. 1999 Sep;25(3):349-53. doi: 10.1016/s8756-3282(99)00175-1. Bone. 1999. PMID: 10495139
-
Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.J Bone Miner Res. 1995 Mar;10(3):458-65. doi: 10.1002/jbmr.5650100318. J Bone Miner Res. 1995. PMID: 7785468 Clinical Trial.
-
Biochemical markers of bone collagen type I metabolism.Ukr Biochem J. 2015 Jan-Feb;87(1):21-32. doi: 10.15407/ubj87.01.021. Ukr Biochem J. 2015. PMID: 26036128 Review.
-
Markers of bone turnover: biochemical and clinical perspectives.J Endocrinol Invest. 2005;28(10 Suppl):8-13. J Endocrinol Invest. 2005. PMID: 16550716 Review.
Cited by
-
Use of calcaneal ultrasound and biochemical markers to assess the density and metabolic state of the bones of adults with hepatic cirrhosis.J Natl Med Assoc. 2007 Sep;99(9):1024-9. J Natl Med Assoc. 2007. PMID: 17913112 Free PMC article.
-
Current understanding of osteoporosis associated with liver disease.Nat Rev Gastroenterol Hepatol. 2009 Nov;6(11):660-70. doi: 10.1038/nrgastro.2009.166. Nat Rev Gastroenterol Hepatol. 2009. PMID: 19881518 Review.
-
Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency.Obes Surg. 2016 Oct;26(10):2425-32. doi: 10.1007/s11695-016-2123-2. Obes Surg. 2016. PMID: 26989059 Free PMC article.
-
Effect of Zoledronic Acid in Hepatic Osteodystrophy: A Double-Blinded Placebo-Controlled Trial.Indian J Endocrinol Metab. 2023 Nov-Dec;27(6):552-558. doi: 10.4103/ijem.ijem_233_23. Epub 2024 Jan 11. Indian J Endocrinol Metab. 2023. PMID: 38371182 Free PMC article.
-
Metabolic bone disease in patients with liver disease.Curr Gastroenterol Rep. 2003 Feb;5(1):71-7. doi: 10.1007/s11894-003-0012-z. Curr Gastroenterol Rep. 2003. PMID: 12530951 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous